Author name: Yali Friedman

Who’s Going To Pay For Global Health? The amazingly swift global response to the SARS outbreak earlier this year demonstrated […]

Seeking a Prescription for Biogenerics No U.S. laws allow for generic versions of off-patent biotech medicines. Several forces are now

Why Merck Missed the Mark S&P’s Herman Saftlas talks about the Street’s reaction to the drug giant’s disappointing earnings report

Biotech: Teva’s Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market

Biotech: Teva’s Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market

Gene Therapy Rebuilds Gums Gene therapy can restore damage caused by severe gum disease, suggest animal studies.

Is Viagra Vulnerable? Eli Lilly’s Cialis lasts for 36 hours–and a $100 million ad blitz will spread the word

It’s Wake-Up Time Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did

It’s Wake-Up Time Kiss your pillow good-bye. A new breed of drugs promises to do for drowsiness what Prozac did

Biotech plans: Boon or fantasy? Having mapped hormones, synthesized molecules and discovered new cell receptors, the Scripps Research Institute wants